tiprankstipranks
Trending News
More News >
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market
Advertisement

Vivos Therapeutics (VVOS) Technical Analysis

Compare
213 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Vivos Therapeutics’s (VVOS) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Vivos Therapeutics is a Buy.
Vivos Therapeutics’s (VVOS) 20-Day exponential moving average is 4.56, while Vivos Therapeutics’s (VVOS) share price is $4.33, making it a Sell.
Vivos Therapeutics’s (VVOS) 50-Day exponential moving average is 4.40, while Vivos Therapeutics’s (VVOS) share price is $4.33, making it a Sell.

Vivos Therapeutics (VVOS) Pivot Points

Aug 30, 2025, 04:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.04
4.27
4.46
4.69
4.88
5.11
5.30
Fibonacci
4.27
4.43
4.53
4.69
4.85
4.95
5.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vivos Therapeutics (VVOS) Moving Averages

Aug 30, 2025, 04:23 PM
Period
Simple
Exponential
MA5
4.58Sell
4.49Sell
MA10
4.45Sell
4.50Sell
MA20
4.52Sell
4.56Sell
MA50
4.71Sell
4.40Sell
MA100
3.58Buy
4.01Buy
MA200
3.72Buy
3.82Buy
Vivos Therapeutics’s (VVOS) 10-Day exponential moving average is 4.50, while Vivos Therapeutics’s (VVOS) share price is $4.33, making it a Sell.
Vivos Therapeutics’s (VVOS) 100-Day exponential moving average is 4.01, while Vivos Therapeutics’s (VVOS) share price is $4.33, making it a Buy.
Vivos Therapeutics’s (VVOS) stock price is $4.33 and Vivos Therapeutics’s (VVOS) 50-day simple moving average is 4.71, creating a Sell signal.
Vivos Therapeutics’s (VVOS) stock price is $4.33 and Vivos Therapeutics’s (VVOS) 100-day simple moving average is 3.58, creating a Buy signal.
Vivos Therapeutics’s (VVOS) stock price is $4.33 and Vivos Therapeutics’s (VVOS) 200-day simple moving average is 3.72, creating a Buy signal.

Vivos Therapeutics (VVOS) Technical Indicators

Aug 30, 2025, 04:23 PM
Name
Value
Implied Action
RSI (14)
46.22
Neutral
STOCH (9,6)
62.24
Neutral
STOCHRSI (14)
62.24
Neutral
MACD (12,26)
-0.06
Buy
ADX (14)
16.92
Buy
Williams %R
-50.00
Buy
CCI (14)
-11.60
Neutral
ATR (14)
0.54
-
Ultimate Oscillator
44.12
Neutral
ROC
-5.46
Sell
Vivos Therapeutics’s (VVOS) Relative Strength Index (RSI) is 46.22, creating a Neutral signal.
Vivos Therapeutics’s (VVOS) Trend Strength Indicator (ADX) is 16.92, creating a Buy signal.
Vivos Therapeutics’s (VVOS) Commodity Channel Index (CCI) is -11.60, creating a Neutral signal.
Vivos Therapeutics’s (VVOS) Price Rate of Change (ROC) is -5.46, creating a Sell signal.

FAQ

Is VVOS a Buy, Hold, or Sell?
Based on VVOS’s technical indicators, VVOS is a Hold.
    What is VVOS’s RSI (14)?
    VVOS’s RSI (14) is 46.22, which suggests VVOS is a Neutral.
      What is VVOS’s MACD?
      VVOS’s MACD is -0.06, which suggests VVOS is a Buy.
        What is VVOS’s 5-day moving average?
        VVOS’s 5-day moving average is 4.58, which suggests VVOS is a Sell.
          What is VVOS’s 20-day moving average?
          VVOS 20-day moving average is 4.52, which suggests VVOS is a Sell.
            What is VVOS’s 50-day moving average?
            VVOS’s 50-day moving average is 4.71, which suggests VVOS is a Sell.
              What is VVOS’s 200-day moving average?
              VVOS’s 200-day moving average is 3.72, which suggests VVOS is a Buy.
                What is VVOS’s Williams % R (14)?
                VVOS’s Williams % R (14) is -50.00, which suggests VVOS is a Buy.
                  What is VVOS’s CCI (14)?
                  VVOS’s CCI (14) is -11.60, which suggests VVOS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis